Duplexed Label-Free G Protein—Coupled Receptor Assays for High-Throughput Screening

This article describes duplexed label-free optical biosensor cellular assays for simultaneously assaying 2 endogenous receptors, the Gq-coupled histamine receptor (H 1) and the Gs-coupled β2-adrenergic receptor (β2AR), in A431 cells. The biosensor cellular assays consist of 2 sequential steps—an initial agonist screening using Sigma LOPAC (Library of Pharmaceutically Active Compounds) and a subsequent antagonist screening using a solution mixture containing the H1 agonist histamine and the β2AR agonist epinephrine. Results showed that costimulating A431 cells with histamine and epinephrine led to an optical response additive to individual responses. The agonist screening not only identified all full agonists for both the H1 and β2 receptors, but also detected pathway-biased ligands for the β2AR. Furthermore, the succeeding antagonist screening documented all known antagonists in the library for either the H1 or β2 receptors. This is the 1st demonstration of a single cellular assay that is capable of screening ligands against 2 GPCRs coupled to distinct G proteins, and highlights the power of pathway-unbiased and label-free biosensor cellular assays for GPCR screens. (Journal of Biomolecular Screening 2008:975-985)

[1]  Ye Fang,et al.  Resonant waveguide grating biosensor for living cell sensing. , 2006, Biophysical journal.

[2]  Z. Salamon,et al.  Techniques: plasmon-waveguide resonance (PWR) spectroscopy as a tool to study ligand-GPCR interactions. , 2003, Trends in pharmacological sciences.

[3]  Ye Fang,et al.  Optical biosensor provides insights for bradykinin B2 receptor signaling in A431 cells , 2005, FEBS letters.

[4]  T. Kenakin.  New Concepts in Drug Discovery: Collateral Efficacy and Permissive Antagonism , 2005, Nature Reviews Drug Discovery.

[5]  B. Kobilka,et al.  Dosage‐dependent switch from G protein‐coupled to G protein‐independent signaling by a GPCR , 2007, The EMBO journal.

[6]  H. Schiöth,et al.  The Repertoire of G-Protein–Coupled Receptors in Fully Sequenced Genomes , 2005, Molecular Pharmacology.

[7]  Christine Williams,et al.  cAMP detection methods in HTS: selecting the best from the rest , 2004, Nature Reviews Drug Discovery.

[8]  Ye Fang,et al.  Optical biosensor differentiates signaling of endogenous PAR1 and PAR2 in A431 cells , 2007, BMC Cell Biology.

[9]  R. Barer,et al.  Refractometry of Living Cells , 1952, Nature.

[10]  Emmanuel Hermans,et al.  Biochemical and pharmacological control of the multiplicity of coupling at G-protein-coupled receptors. , 2003, Pharmacology & therapeutics.

[11]  A. Hopkins,et al.  The druggable genome , 2002, Nature Reviews Drug Discovery.

[12]  Ye Fang,et al.  Label-free cell-based assays with optical biosensors in drug discovery. , 2006, Assay and drug development technologies.

[13]  D. Cooper,et al.  Organization and Ca2+ regulation of adenylyl cyclases in cAMP microdomains. , 2007, Physiological reviews.

[14]  E. Butcher.  Can cell systems biology rescue drug discovery? , 2005, Nature Reviews Drug Discovery.

[15]  I. Verlaan,et al.  Histamine as a growth factor and chemoattractant for human carcinoma and melanoma cells: action through Ca2(+)-mobilizing H1 receptors , 1990, The Journal of cell biology.

[16]  K. Neve,et al.  Sensitization of adenylate cyclase by Gαi/o-coupled receptors , 2005 .

[17]  A. Strosberg,et al.  The human carcinoma cell line A431 possesses large numbers of functional β‐adrenergic receptors , 1984, FEBS letters.

[18]  Matthew A. Cooper,et al.  Optical biosensors in drug discovery , 2002, Nature Reviews Drug Discovery.

[19]  Ye Fang,et al.  Non-invasive optical biosensor for assaying endogenous G protein-coupled receptors in adherent cells. , 2007, Journal of pharmacological and toxicological methods.

[20]  Ye Fang,et al.  Label-Free Profiling of Ligands for Endogenous Gpcrs Using a Cell-Based High-Throughput Screening Technology , 2006 .

[21]  W. Kolch,et al.  Cell-type specific integration of cross-talk between extracellular signal-regulated kinase and cAMP signaling. , 2000, Molecular pharmacology.

[22]  Ye Fang,et al.  Characteristics of dynamic mass redistribution of epidermal growth factor receptor signaling in living cells measured with label-free optical biosensors. , 2005, Analytical chemistry.

[23]  R. Mailman.  GPCR functional selectivity has therapeutic impact. , 2007, Trends in pharmacological sciences.

[24]  Ye Fang,et al.  Label‐free optical biosensor for ligand‐directed functional selectivity acting on β2 adrenoceptor in living cells , 2008, FEBS letters.

[25]  Graeme Milligan,et al.  High-content assays for ligand regulation of G-protein-coupled receptors. , 2003, Drug discovery today.

[26]  R. Iyengar,et al.  Signaling Networks The Origins of Cellular Multitasking , 2000, Cell.

[27]  Ye Fang,et al.  Membrane protein microarrays. , 2002, Journal of the American Chemical Society.

[28]  Michel Bouvier,et al.  Oligomerization of G-protein-coupled transmitter receptors , 2001, Nature Reviews Neuroscience.

[29]  Ye Fang,et al.  Label-free cell-based assays for GPCR screening. , 2008, Combinatorial chemistry & high throughput screening.

[30]  M. Bouvier,et al.  The evasive nature of drug efficacy: implications for drug discovery. , 2007, Trends in pharmacological sciences.

[31]  R. Barer,et al.  Refractometry of Living Cells Part I. Basic Principles , 1954 .

[32]  G. Milligan,et al.  Tailoring cAMP-signalling responses through isoform multiplicity. , 1997, Trends in biochemical sciences.

[33]  J. Lahiri,et al.  G protein-coupled receptor microarrays for drug discovery. , 2003, Drug discovery today.

[34]  G. Liapakis,et al.  Synergistic contributions of the functional groups of epinephrine to its affinity and efficacy at the beta2 adrenergic receptor. , 2004, Molecular pharmacology.

[35]  J. Drews.  Drug discovery: a historical perspective. , 2000, Science.

[36]  M. Sallese,et al.  G protein-coupled receptors: heterologous regulation of homologous desensitization and its implications. , 1996, Trends in pharmacological sciences.

[37]  B. Kholodenko.  Four-dimensional organization of protein kinase signaling cascades: the roles of diffusion, endocytosis and molecular motors , 2003, Journal of Experimental Biology.

[38]  Robert J. Lefkowitz,et al.  Transduction of Receptor Signals by ß-Arrestins , 2005, Science.

[39]  Xavier Deupi,et al.  Probing the β2 Adrenoceptor Binding Site with Catechol Reveals Differences in Binding and Activation by Agonists and Partial Agonists* , 2005, Journal of Biological Chemistry.

[40]  Olgatina Bucco,et al.  G-Protein-Coupled Receptors in Drug Discovery: Nanosizing Using Cell-Free Technologies and Molecular Biology Approaches , 2005, Journal of biomolecular screening.